# Can Your Ring Predict Ovulation?

A smart ring can measure cycle-linked physiology. It cannot directly measure ovulation. The useful signal is mainly a sustained temperature pattern after ovulation, sometimes combined with resting heart rate, HRV, and respiratory-rate changes. That supports cycle awareness; it does not support treating a ring-generated ovulation day or fertile-window label as ground truth. ([JMIR](https://www.jmir.org/2025/1/e60667/))

## Verdict for exported metrics

- Skin-temperature trend relative to personal baseline: **include**.

- Sustained temperature-shift trend: **include**.

- "Ovulation detected": **exclude**.

- "Ovulation day": **exclude**.

- "Predicted ovulation day": **exclude**.

- "Fertile window": **exclude**.

- "Fertile today" or "non-fertile today": **exclude**.

- "Safe day" for pregnancy avoidance: **exclude**.

- Proprietary "fertility," "cycle health," or "reproductive readiness" composites: **exclude**.


The distinction is the metric label. A ring can export a temperature trend because that is close to what it measures. Once the same signal is renamed as ovulation, fertility, or contraceptive safety, the label outruns the evidence. The strongest recent synthesis found useful performance around ovulation, but the certainty of the wearable evidence was graded low to very low, exact-day accuracy was much weaker than broad-window accuracy, and irregular-cycle performance was less reassuring in prospective cohort data. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

## What the physiology can support

Ovulation is followed by a luteal-phase rise in progesterone, and progesterone increases body temperature. This is the basis of basal-body-temperature fertility-awareness methods and explains why rings can often detect a post-ovulatory shift. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

The signal is delayed. Temperature-based methods are better at showing that ovulation has probably already occurred than at identifying the fertile days before ovulation. In a prospective cohort that used ultrasound and serum hormones to determine ovulation, the authors noted that basal body temperature rises about 2 days after the LH peak and is mainly useful for retrospective confirmation. ([Springer](https://link.springer.com/article/10.1186/s12958-022-00993-4))

A ring does not measure follicle rupture, ovarian ultrasound findings, serum progesterone, or urinary LH. Oura's published algorithm used finger-temperature signal processing and compared its estimates with self-reported positive ovulation-predictor-kit results. Ava studies also used urinary LH testing as the ovulation reference while the wearable measured physiologic signals such as skin temperature, pulse, perfusion, and breathing rate. ([JMIR](https://www.jmir.org/2025/1/e60667/), [JMIR](https://www.jmir.org/2019/4/e13404/))

## Prediction is harder than confirmation

The biological fertile window includes the days before ovulation, not just the day after the temperature rise. A device that detects a post-ovulatory temperature shift can miss the earlier high-fertility days unless its algorithm successfully predicts ahead of the shift. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

A 2026 systematic review and Bayesian network meta-analysis found that wearable digital technologies had pooled fertility-window-detection accuracy of 0.88, sensitivity of 0.79, and specificity of 0.80 across included studies. That sounds strong until the timing is separated: exact ovulation-day accuracy was 0.56 with a very wide 95% CI of 0.00-1.00, accuracy within ±1 day was 0.61, and accuracy became much higher only when the window widened to ±2 or ±3 days. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

That timing gap matters. A ±2- or ±3-day estimate can be useful for understanding patterns, symptoms, or training response. It is not the same thing as a prospective fertile-window label validated enough to be exported as reproductive truth for conception timing. For Oura specifically, the Fertile Window manual says the feature is not intended for contraception. ([Nature](https://www.nature.com/articles/s41746-025-02320-8), [Oura](https://support.ouraring.com/hc/en-us/articles/30561106990227-Fertile-Window-User-Manual))

## What systematic reviews say

A 2026 systematic review and Bayesian network meta-analysis of wearable digital technology for fertility-window and menstrual-cycle detection included 27 studies, with 13 studies on wearable ovulation detection, and concluded that wearables performed better than calendar and basal-temperature methods in pooled analyses. The same review downgraded the wearable evidence because of risk of bias, inconsistency, imprecision, and publication-bias concerns. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

A 2024 systematic review of wearable reproductive-health technology found 13 eligible studies published between July 1, 2012, and July 1, 2022, including rings, wrist wearables, ear devices, and vaginal sensors. It concluded that wearables are promising for menstrual and fertility tracking but emphasized small pilot designs, limited validation, environmental and behavioral confounding of skin temperature, and the need for rigorous trials before broad marketing claims. ([JMIR](https://www.jmir.org/2024/1/e45139/))

Together, the reviews support a narrow claim: wearables can detect cycle-associated physiologic patterns, especially temperature shifts around ovulation. They do not support a broad claim that a ring can predict the exact fertile window accurately enough to be exported as reproductive truth. ([Nature](https://www.nature.com/articles/s41746-025-02320-8), [JMIR](https://www.jmir.org/2024/1/e45139/))

## Ring-specific evidence

A 2025 Oura Ring validation study reported detection of 1,113 of 1,155 ovulatory cycles, or 96.4%, with a mean absolute error of 1.26 days compared with self-reported positive ovulation-predictor-kit results. In that study, 68.0% of detections were within 1 day, 87.9% within 2 days, and 95.0% within 3 days. ([JMIR](https://www.jmir.org/2025/1/e60667/))

That study should not be used as the sole basis for ovulation accuracy claims. The authors were Oura employees, the study used Oura commercial-user data, the paper reports that Oura's science and legal team reviewed and approved the data-analysis protocol, and the paper does not report independent IRB or external ethics-board review. The data are not publicly available except at Oura's discretion. The reference standard was self-reported positive LH testing, not ultrasound-confirmed ovulation, and the analysis included only ovulatory cycles, so it could not evaluate false alarms in anovulatory cycles. ([JMIR](https://www.jmir.org/2025/1/e60667/))

The same Oura paper stated that it did not have data on menstrual-cycle disorders and specifically warned that conditions such as PCOS, thyroid disorders, hyperprolactinemia, IVF treatment, and luteal-phase defect could alter algorithm performance. That limitation directly affects the people for whom prediction would often be most valuable. ([JMIR](https://www.jmir.org/2025/1/e60667/))

The Oura study did not find significant accuracy differences by typical cycle variability, which is more favorable than the prospective irregular-cycle cohorts below. That finding should still be read cautiously because the dataset included only ovulatory cycles, used self-reported positive LH tests as the benchmark, and lacked menstrual-disorder history. ([JMIR](https://www.jmir.org/2025/1/e60667/))

## Wrist-wearable evidence and the irregular-cycle problem

A 2019 Ava bracelet study reported 90% fertile-window accuracy, with sensitivity of 0.81 and specificity of 0.93, using urinary LH testing as the reference. The study population was restricted to women with regular cycles, and the final validation set after compliance exclusions was small: 85 cycles from 24 users. ([JMIR](https://www.jmir.org/2019/4/e13404/))

That Ava study also had clear conflicts of interest. Several authors were current or former Ava employees, one author was on Ava's medical advisory board, and the work was supported by a Swiss Commission for Technology and Innovation grant. The findings should be interpreted with that in mind. ([JMIR](https://www.jmir.org/2019/4/e13404/))

Academic prospective wearable evidence in irregular cycles is much less reassuring. A 2022 prospective cohort using a Huawei Band 5, ear-temperature measurements, ovarian ultrasound, and serum hormones found much better performance in regular cycles than irregular cycles. In regular cycles, fertile-window prediction accuracy was 87.46%, sensitivity was 69.30%, specificity was 92.00%, and AUC was 0.8993. In irregular cycles, accuracy fell to 72.51%, sensitivity fell to 21.00%, specificity was 82.90%, and AUC was 0.5808. Huawei provided the smartphones, smart bands, and thermometers used in that study, while the paper declared no competing interests. ([Springer](https://link.springer.com/article/10.1186/s12958-022-00993-4))

A 2025 prospective cohort using a Huawei Band 6 Pro also found lower performance in irregular cycles. The regular-cycle fertile-window algorithm had accuracy of 85.47%, sensitivity of 70.07%, specificity of 89.77%, and AUC of 0.869; the irregular-cycle algorithm had accuracy of 79.85%, sensitivity of 42.79%, specificity of 87.28%, and AUC of 0.763. The study reported research grants from Huawei Device Co Ltd. ([ScienceDirect](https://www.sciencedirect.com/science/article/abs/pii/S1472648325000021))

The practical problem is not average accuracy. It is asymmetric failure. For conception, a false negative can mean missing a fertile window. For contraception, a false reassurance can mean unplanned pregnancy. The current wearable evidence supports using ring-derived ovulation or fertility labels as algorithmic estimates rather than standalone exported ground-truth metrics. ([Nature](https://www.nature.com/articles/s41746-025-02320-8), [Oura](https://support.ouraring.com/hc/en-us/articles/30561106990227-Fertile-Window-User-Manual))

## The marketing inflation

"Cycle insights" is a defensible broad consumer phrase when the output is shown as a trend with context. "Ovulation prediction" is a stronger claim. "Fertile window" is stronger still. "Safe day" or "non-fertile day" is the highest-stakes claim and should be excluded. ([Nature](https://www.nature.com/articles/s41746-025-02320-8), [Oura](https://support.ouraring.com/hc/en-us/articles/30561106990227-Fertile-Window-User-Manual))

The product-label reality is that Oura's Fertile Window feature can display estimated fertile window, estimated ovulation day, confirmed fertile window, confirmed ovulation day, and "Chance of conception" labels. Oura's user manual describes the feature as an aid in ovulation prediction to facilitate conception and explicitly says it is not intended for contraception. That does not change the export decision. It means the product output exists, but the product output is still an algorithmic interpretation layer. ([Oura](https://support.ouraring.com/hc/en-us/articles/30561106990227-Fertile-Window-User-Manual))

The validated narrow claim is that wearables can detect physiologic changes associated with the menstrual cycle, especially temperature patterns after ovulation. The inflated claim is that a ring can identify the exact day of ovulation or the current fertile window accurately enough for family planning decisions. That gap is the finding. ([Nature](https://www.nature.com/articles/s41746-025-02320-8), [JMIR](https://www.jmir.org/2025/1/e60667/), [Oura](https://support.ouraring.com/hc/en-us/articles/30561106990227-Fertile-Window-User-Manual))

## Conflict-of-interest check

The 2026 systematic review reported no competing interests, but it rated the certainty of wearable evidence as low to very low because of bias, inconsistency, and imprecision. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

The 2024 systematic review reported no declared conflicts and concluded that wearable reproductive-health technology needs more rigorous, larger, and more validated studies before strong clinical or family-planning claims are made. ([JMIR](https://www.jmir.org/2024/1/e45139/))

The 2025 Oura Ring validation study was authored by Oura employees, used Oura commercial data, used self-reported LH results rather than ultrasound-confirmed ovulation, and did not publicly release the dataset. This is a direct industry conflict for ring-based ovulation accuracy claims. ([JMIR](https://www.jmir.org/2025/1/e60667/))

The 2019 Ava bracelet study reported several direct author ties to Ava, including current or former employment and medical-advisory-board involvement. This is a direct industry conflict for Ava's fertile-window accuracy claims. ([JMIR](https://www.jmir.org/2019/4/e13404/))

The 2022 Huawei Band 5 cohort declared no competing interests, but Huawei provided the phones, bands, and thermometers used in the study. The 2025 Huawei Band 6 Pro cohort reported research grants from Huawei Device Co Ltd. ([Springer](https://link.springer.com/article/10.1186/s12958-022-00993-4), [ScienceDirect](https://www.sciencedirect.com/science/article/abs/pii/S1472648325000021))

## Quick reference values

- Wearable digital technologies, pooled fertility-window detection: accuracy 0.88, sensitivity 0.79, specificity 0.80. Evidence certainty was downgraded to very low. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

- Exact ovulation-day detection in the 2026 synthesis: accuracy 0.56, with a very wide 95% CI of 0.00-1.00. Within ±1 day: 0.61. Within ±2 days: 0.90. Within ±3 days: 0.88. ([Nature](https://www.nature.com/articles/s41746-025-02320-8))

- Oura Ring 2025 company-authored validation: 96.4% detection of ovulatory cycles, mean absolute error 1.26 days, benchmarked against self-reported positive LH tests rather than ultrasound-confirmed ovulation. ([JMIR](https://www.jmir.org/2025/1/e60667/))

- Ava bracelet 2019 company-conflicted validation: 90% fertile-window accuracy, but validation after compliance exclusions used 85 cycles from 24 users. ([JMIR](https://www.jmir.org/2019/4/e13404/))

- Academic 2022 wearable cohort with ultrasound and serum hormones: regular-cycle AUC 0.8993; irregular-cycle AUC 0.5808, with irregular-cycle sensitivity only 21.00%. Huawei provided the phones, bands, and thermometers. ([Springer](https://link.springer.com/article/10.1186/s12958-022-00993-4))

- 2025 Huawei Band 6 Pro wearable cohort: regular-cycle AUC 0.869; irregular-cycle AUC 0.763, again showing degraded performance in irregular cycles. The study reported research grants from Huawei Device Co Ltd. ([ScienceDirect](https://www.sciencedirect.com/science/article/abs/pii/S1472648325000021))


## Practical interpretation

- Use ring temperature trends for personal pattern awareness. That is the cleanest supported use.

- Do not export "ovulation day," "fertile window," "fertile today," or "safe day" as ground-truth columns.

- Do not use company-authored validation studies as the sole basis for reproductive-health claims.

- For people trying to conceive, a wearable can serve as a low-stakes prompt to pay closer attention or confirm with LH testing. It should not be treated as a standalone fertile-window predictor.

- For pregnancy avoidance, ring-based ovulation or fertility labels are **exclude**. Diagnostic accuracy against LH tests is not the same as contraceptive effectiveness.

- For irregular cycles, PCOS, thyroid disorders, hyperprolactinemia, luteal-phase defects, IVF or fertility treatment, hormonal contraception, hormone replacement therapy, temperature-affecting medications, or other contexts where errors carry higher consequences, ovulation and fertile-window labels are **exclude**.


## References

- Shi Y, Wang CC, Yang Y, et al. [The diagnostic accuracy of wearable digital technology in detecting fertility window and menstrual cycles: a systematic review and Bayesian network meta-analysis](https://www.nature.com/articles/s41746-025-02320-8). _npj Digital Medicine_. 2026;9:139. DOI: [10.1038/s41746-025-02320-8](https://doi.org/10.1038/s41746-025-02320-8).

- Lyzwinski L, Elgendi M, Menon C. [Innovative approaches to menstruation and fertility tracking using wearable reproductive health technology: systematic review](https://www.jmir.org/2024/1/e45139/). _Journal of Medical Internet Research_. 2024;26:e45139. DOI: [10.2196/45139](https://doi.org/10.2196/45139).

- Thigpen N, Patel S, Zhang X. [Oura Ring as a Tool for Ovulation Detection: Validation Analysis](https://www.jmir.org/2025/1/e60667/). _Journal of Medical Internet Research_. 2025;27:e60667. DOI: [10.2196/60667](https://doi.org/10.2196/60667).

- Goodale BM, Shilaih M, Falco L, Dammeier F, Hamvas G, Leeners B. [Wearable sensors reveal menses-driven changes in physiology and enable prediction of the fertile window: observational study](https://www.jmir.org/2019/4/e13404/). _Journal of Medical Internet Research_. 2019;21(4):e13404. DOI: [10.2196/13404](https://doi.org/10.2196/13404).

- Yu JL, Su YF, Zhang C, et al. [Tracking of menstrual cycles and prediction of the fertile window via measurements of basal body temperature and heart rate as well as machine-learning algorithms](https://link.springer.com/article/10.1186/s12958-022-00993-4). _Reproductive Biology and Endocrinology_. 2022;20:118. DOI: [10.1186/s12958-022-00993-4](https://doi.org/10.1186/s12958-022-00993-4).

- Luo C, Su YF, Ren YY, et al. [Prediction of the fertile window and menstruation with a wearable device via machine-learning algorithms](https://www.sciencedirect.com/science/article/abs/pii/S1472648325000021). _Reproductive BioMedicine Online_. 2025;51(1):104795. DOI: [10.1016/j.rbmo.2025.104795](https://doi.org/10.1016/j.rbmo.2025.104795).

- Oura Health Oy. [Fertile Window User Manual](https://support.ouraring.com/hc/en-us/articles/30561106990227-Fertile-Window-User-Manual). FD-LDS2 version 14. 5/2026.